论文信息 - Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC). - 字舞流文

Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).

Jeffrey W. Clark | A. Zhu | D. Ryan | J. Cusack | T. Hong | P. Ulintz | K. Hardiman | M. Hazar-Rethinam | A. Parikh | S. McDuff | L. Goyal | C. Weekes | R. Corcoran | Jill N. Allen | L. Blaszkowsky | J. Wo | B. Nadres | E. V. van Seventer | Hui Zheng | I. Fetter